Trial intelligence / Profile preview

Betamethasone versus methotrexate versus combination therapy for severe alopecia areata

IRCT20181226042136N1Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Jul 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in alopecia areata comparing Betamethasone, Methotrexate and Methotrexate + betamethasone (3 arms). Primary endpoints: Photographic score, Visual analogue scale score and 1 more. Started Jul 2017; status: completed.

02

Drugs

betamethasonemethotrexate
03

Conditions

alopecia areata

Beyond the preview

Go deeper on IRCT20181226042136N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20181226042136N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call